Altrika, the Sheffield-based biotechnology firm, has been sold by Ilika to Adiposet for £0.1m. [31-Dec-2012]
DCC Healthcare is to acquire Kent Pharma, the Ashford-based pharmaceuticals company with 304 staff, for £58m. [31-Dec-2012]
Valspar is setting up a new 7,800 sq ft headquarters for its paints business at the IQ Winnersh business park near Reading. [31-Dec-2012]
Scientific & Technical Gases is to set up a new £2m 10,000 sq ft manufacturing plant at a former Air Liquide site in Newcastle under Lyme by 2015, with the creation of 20 jobs. [20-Dec-2012]
Huntingdon Life Sciences is to shed a further 100 jobs at sites in Huntingdon and Suffolk by the end of January. [17-Dec-2012]
Epistem is to raise £4.3m in a share placing to fund the commercial development of its Genedrive diagnostics product. [10-Dec-2012]
LondonPharma is relocating its Norwich-based drug development business to the Norwich Research Park Innovation Centre. [10-Dec-2012]
TTS Pharma is to relocate its diagnostic blood test products business from Bristol to Liverpool Science Park in early 2013. [03-Dec-2012]
Oxford Pharmascience has raised £2m in a share placing to fund the expansion of its pharmaceutical technologies business. [27-Nov-2012]
Crown Paints is considering plans to shed 60 jobs in Hull and ten in Darwen, as part of a multi-million pound investment in new technology. [26-Nov-2012]
The University of Edinburgh is planning to build a new £40m biological sciences teaching and research centre. [26-Nov-2012]
Catalent is to shed about 45 of the 500 jobs at its pharmaceuticals production plant in Swindon by the end of the year. [19-Nov-2012]
Molecular Devices is to close its bioanalytical technology facility in Hampshire in March, with the loss of up to 50 jobs. [19-Nov-2012]
Corin, the Cirencester-based orthopaedics manufacturer with 100 staff, is to be acquired by 2IL Orthopaedics of Italy for £30m. [13-Nov-2012]
AFC Energy has secured a £5m European grant to build an alkaline fuel cell system at the ICL chemical plant in Grays, Essex. [08-Nov-2012]
Queen's University Belfast has secured funding of £32m to set up a Centre for Experimental Medicine by 2016. [01-Nov-2012]
Luxfer is to invest £13m in the expansion of its Magnesium Elektron and MEL Chemicals production plants in Greater Manchester. [29-Oct-2012]
Selden has acquired the Jeyes Professional cleaning brand and will transfer production and ten jobs from Preston and Mold to Buxton. [29-Oct-2012]
AstraZeneca has secured government funding of £5m to help develop a BioScience cluster at its Alderley Edge research site, in order to attract innovative pharmaceutical companies. [25-Oct-2012]
Redx Pharma is to create 119 jobs at its Liverpool-based pharmaceuticals development business, as one of 130 projects to benefit from the government's £2.4bn Regional Growth Fund. [22-Oct-2012]
Wiltshire Council, Trebor Developments and Wrenbridge Land have secured a £10m government grant to build a £180m life sciences business park at Porton Down, with the creation of more than 2,000 jobs over the next ten years. [22-Oct-2012]
Yanco has acquired a 44,000 sq ft unit in south Liverpool for a new insecticide production facility. [22-Oct-2012]
Alliance Pharma has acquired Opus Group Holdings, the distributor of skin creams and cleansers, for £8m. [22-Oct-2012]
Seven Seas is considering plans to close its vitamins factory in Hull over the next few years, with the loss of up to 260 jobs. [17-Oct-2012]
Amdipharm, the Essex-based pharmaceuticals marketing company, is to be acquired by private equity firm Cinven for £367m. [16-Oct-2012]
Infinergy Technology is seeking permission to build a £16m biotechnology-based power station at Ricall Business Park in Selby, with the creation of 36 jobs. [11-Oct-2012]
Victrex is to invest £90m in the development of a new PEEK polyaryletherketone production plant at its Hillhouse site in Lancashire by 2015. [04-Oct-2012]
Integrated Magnetic Systems is to set up a protein production facility at the Prospect Business Centre in Dundee. [04-Oct-2012]
SAFC is to set up a new powder manufacturing facility at its chemicals plant in Irvine, with the creation of 24 jobs. [27-Sep-2012]
Molplex is planning to expand its Newcastle-based drug discovery automation business with a new base in Liverpool or Manchester, having secured an investment from the North West Fund. [25-Sep-2012]
SNF Oil & Gas is seeking permission to set up a polyacrylamide emulsion manufacturing facility in Billingham by 2014, with the creation of 250 jobs. [17-Sep-2012]
Unilever is to proceed with plans for a new £40m manufacturing and IT hub for its personal care products at Port Sunlight, with the creation of 150 jobs. [17-Sep-2012]
Strathclyde Pharmaceuticals is to invest in additional facilities for its East Kilbride-based pharmaceutical wholesaling business, with the creation of 40 jobs. [13-Sep-2012]
Jeyes is to conduct a review of its cleaning products manufacturing plant in East Kilbride, casting doubt on the future of 110 jobs. [10-Sep-2012]
Benchmark Holdings has acquired the Novartis Animal Health vaccines factory in Braintree for undisclosed terms. [06-Sep-2012]
F2G has secured £19m from Advent Life Sciences and Novartis Bioventures to fund the expansion of its Manchester-based biotechnology business. [06-Sep-2012]
Briar Chemicals is to invest in a new waste water treatment plant and production facility at its site in Norwich, following its acquisition by Aurelius. [04-Sep-2012]
York Potash has selected a site at Dove Nest Farm near Whitby as the preferred location for a new potash mine, with the creation of up to 5,000 jobs. [03-Sep-2012]
ACM Global Central Laboratory is to relocate its York-based clinical testing services business to a 14,000 sq ft office at The Edge later this year. [30-Aug-2012]
Christeyns UK has expanded its detergents and chemicals business with the acquisition of a 50% stake in Klenzan, the Warrington-based food hygiene firm, for undisclosed terms. [30-Aug-2012]
Medical Research Council is to provide £60m of funding for the expansion of the Institute of Genetics & Molecular Medicine at the University of Edinburgh over the next five years. [28-Aug-2012]
Clinigen is looking to raise £10m in a flotation on Aim to fund the expansion of its Staffordshire-based pharmaceuticals business. [28-Aug-2012]
United Drug is to acquire the clinical services businesses of Bilcare for £39m, including 195 staff in South Wales and the US. [21-Aug-2012]
South Devon Healthcare NHS Foundation Trust is planning to set up a new 67,000 sq ft pharmaceutical manufacturing unit in Paignton, with the relocation of 85 staff from three existing sites. [20-Aug-2012]
Mercury Pharma, the London-based pharmaceuticals company, is to be acquired by private equity firm Cinven for £465m. [20-Aug-2012]
Oxford University has agreed a deal to acquire the Park Hospital site in Headington, in order to develop a new medical science centre with four laboratories and up to 3,000 staff. [16-Aug-2012]
GlaxoSmithKline has raised £172m from the sale of 25 Australian pharmaceutical brands to Aspen Pharmacare. [16-Aug-2012]
ICON Development Solutions is to set up a 40,000 sq ft Centre of Excellence for Translational Medicine at the Citylabs scheme in Manchester. [09-Aug-2012]
Versalis of Italy is to invest about £40m in the expansion of elastomer production capacity at its site in Grangemouth, with the creation of 20 jobs. [07-Aug-2012]
Pfizer has sold its 213-acre research site in Sandwich, Kent, to a private consortium backed by Palmer Capital, and will lease back 250,000 sq ft of office and laboratory space. [06-Aug-2012]
Alliance Pharma has acquired three anti-malarial brands from AstraZeneca for an initial £4.2m. [02-Aug-2012]
GlaxoSmithKline is to operate a new £10m medical science research centre at the Olympics testing laboratory in Harlow, with funding from the Medical Research Council and the Department of Health. [01-Aug-2012]
Huntingdon Life Sciences is to shed about 100 jobs at its pharmaceutical research laboratories in Cambridgeshire and Suffolk. [01-Aug-2012]
William Sinclair is to relocate its Lincoln-based horticultural business to a new site at New Bridge Road in Ellesmere Port over the next five years, with the creation of up to 250 jobs. [31-Jul-2012]
The Physiological Society is to relocate its London headquarters to the 8,100 sq ft Priory Court office on Farringdon Lane. [31-Jul-2012]
Huntsman is to invest £15m in the expansion of its titanium dioxide plant in Hartlepool by 2014, with the creation of 90 jobs. [31-Jul-2012]
Sanofi is planning to double the 40-strong workforce at its new Flutiform asthma inhaler production line at Holmes Chapel in Cheshire over the next two years. [19-Jul-2012]
Plant Impact is to relocate the headquarters of its biotechnology business from Preston to its Rothamsted research centre in Hertfordshire in September. [17-Jul-2012]
GlaxoSmithKline is to acquire US-based Human Genome Sciences for £1.9bn, in order to gain new treatments for lupus, diabetes and heart disease. [17-Jul-2012]
Cherwell Laboratories is planning to expand the 56-strong workforce at its Bicester-based environmental testing kits business by 20%. [16-Jul-2012]
PsiOxus Therapeutics has secured a £22m investment from Imperial Innovations and others to fund the expansion of its Oxford-based biotechnology business. [10-Jul-2012]
Bronnley & Co is to shed up to 41 of the 61 jobs at its luxury soap business in Brackley, in order to outsource production and warehousing. [09-Jul-2012]
Jeyes has confirmed plans to close its cleaning products factory in Mold early next year, with the loss of 117 jobs. [04-Jul-2012]
Banner Chemicals has acquired KMZ Chemicals, the Northampton-based chemicals distributor, for undisclosed terms. [04-Jul-2012]
Oxford BioMedica is to raise up to £16m in a share placing to fund the commercial development of its gene delivery technology. [02-Jul-2012]
Redx Pharma is seeking government funding to set up a £11m superbug treatment research centre in Liverpool, with the creation of 119 jobs. [28-Jun-2012]
Gelicity UK is planning to double the 45-strong workforce at its Flint-based skincare business this year, and will relocate to a larger 18,500 sq ft site on the Castle Industrial Estate. [28-Jun-2012]
Forensic Access is to set up a new forensic science facility at Sand Hutton in North Yorkshire, and plans to double the 15-strong workforce. [28-Jun-2012]
Aesica is to create 100 new jobs at its Queenborough pharmaceuticals plant on the Isle of Sheppey over the next three years. [26-Jun-2012]
LifeScan is to invest £9.5m in the transfer of its blood glucose monitoring research operations to its main site in Inverness, securing 1,100 jobs and creating 19 new jobs. [25-Jun-2012]
University of Liverpool is to relocate 50 infectious disease researchers to an 8,000 sq ft laboratory and office at Liverpool Science Park from July. [25-Jun-2012]
Unilever is to invest £40m in the expansion of its Port Sunlight shampoo and soaps factory on Merseyside, with the creation of 150 jobs. [18-Jun-2012]
Proximagen, the biotechnology firm with 40 staff in London and Cambridge, is to be acquired by US-based Upsher-Smith for at least £223m. [14-Jun-2012]
GlaxoSmithKline is to buy the Toctino eczema treatment from Basilea of Switzerland for up to £200m, in order to expand its Stiefel dermatology business. [13-Jun-2012]
Whitford is to relocate its Runcorn-based coatings business and about 80 staff to a four-acre site nearby in August, with the creation of ten new jobs. [06-Jun-2012]
Nova Laboratories is to expand the 160-strong workforce at its Leicestershire-based pharmaceuticals business with an unspecified number of new jobs, having won approval for a new leukaemia treatment. [30-May-2012]
Invest in Nottingham is in discussions with an unnamed Indian pharmaceuticals company that is considering Nottingham, Liverpool and Kent as potential locations for a new UK headquarters. [29-May-2012]
Phoenix Medical Supplies is setting up an 8,000 sq ft office for its pharmaceutical wholesaling business at Priory Court in Preston Brook, Runcorn. [29-May-2012]
GlaxoSmithKline and AstraZeneca have secured funding of £180m from the European Commission to collaborate in the development of new antibiotics. [24-May-2012]
Vitrology, the Glasgow-based biotechnology firm with 38 staff, is to be acquired by SGS of Switzerland. [22-May-2012]
Arcis Biotechnology of Daresbury has acquired Altos Medical, the US developer cleaning products for hospitals, for £2.5m. [22-May-2012]
Allergan is reported to be seeking a suitable location in in the Thames Valley for a new 180,000 sq ft headquarters for its pharmaceuticals business. [21-May-2012]
Chime Communications has acquired a 51% stake in Harvey Walsh, the Cheshire-based provider of data services to the pharmaceutical industry and the NHS, for an initial £2.2m. [17-May-2012]
GlaxoSmithKline is to acquire Cellzome, the protein research firm with sites in Cambridge and Germany, for £61m. [16-May-2012]
Patheon is planning to close its pharmaceuticals production plant in Swindon by the end of 2014, with the loss of up to 400 jobs. [14-May-2012]
Angel Biotechnology has acquired a 6,500 sq ft collagen manufacturing plant in Glasgow for £0.2m, in order to expand its new Angel Biomedical subsidiary. [10-May-2012]
Equateq, the Isle of Lewis-based manufacturer of pharmaceutical ingredients with about 50 staff, has been acquired by BASF of Germany for undisclosed terms. [10-May-2012]
Scientific & Technical Gases is to expand the 50-strong workforce at its Staffordshire-based gas manufacturing business with ten new jobs over the next year. [08-May-2012]
Retroscreen is to raise £15m in a flotation to fund the expansion of its London-based medical trials business. [03-May-2012]
Focus Pharmaceuticals is setting up a 34,000 sq ft warehouse at the Hindley Green business park in Wigan. [30-Apr-2012]
Synthomer is to close its chemicals plant in Batley later this year, with the loss of 43 jobs. [25-Apr-2012]
Life Technologies is to build a new £12m biosciences production plant at its site in Glasgow by 2014, with the creation of 30 jobs. [24-Apr-2012]
AstraZeneca is to acquire Ardea Biosciences, the US pharmaceuticals firm, for £782m. [23-Apr-2012]
Jeyes is to shed up to 85 jobs at its Thetford-based cleaning products business, in order to stop making private label products. [23-Apr-2012]
Retroscreen Virology is planning to raise up to £10m in a flotation on Aim to fund the expansion of its London-based medical trials business. [23-Apr-2012]
Bronnley & Co is considering plans to outsource the manufacture of its soap products, and the remaining staff would relocate from its Brackley factory to a new office. [18-Apr-2012]
Pharmacells has bought the assets of Immunosolv, the Edinburgh-based biotechnology firm, out of liquidation. [17-Apr-2012]
Johnson Matthey is said to be planning to shed up to 30 of the 300 jobs at its Ammonia, Methanol & Gas operation in Clitheroe. [12-Apr-2012]
Protega Coatings, the West Bromwich-based industrial paints manufacturer with 42 staff, has been sold out of administration by FRP Advisory to an unnamed company. [11-Apr-2012]
Cat Tech International, the North Lincolnshire-based provider of catalyst handling services, has undergone a management buy-out from Clean Harbors, with backing from Maven Capital Partners. [05-Apr-2012]
Bayer CropScience has sold its 114-acre manufacturing site in Norwich, which has 260 staff, to Aurelius of Germany for undisclosed terms. [05-Apr-2012]
Dechra Pharmaceuticals is to acquire Eurovet Animal Health, the Dutch veterinary pharmaceuticals supplier with a site in Cambridge, from AUV Holding for £112m. [05-Apr-2012]
ReNeuron Group has raised £9.4m in a share placing to fund the expansion of its Guildford-based stem cell technology business. [03-Apr-2012]
Ingenza is to create up to 40 jobs at its new biotech laboratory at the Roslin BioCentre in Midlothian. [03-Apr-2012]
DBG has acquired TAG Medical, the Nottingham-based provider of medical equipment testing services, for undisclosed terms. [29-Mar-2012]
GlaxoSmithKline is to invest £500m in the expansion of its pharmaceutical manufacturing facilities in the UK, including a new £350m plant at Ulverston in Cumbria, with the creation of up to 1,000 jobs. [22-Mar-2012]
Sanofi is to close its pharmaceuticals factory at Fawdon in Newcastle in 2015, with the loss of up to 450 jobs. [15-Mar-2012]
Whitford has acquired a 70,000 sq ft property at Manor Park in Runcorn to expand its fluoropolymer coatings production and warehouse operations. [15-Mar-2012]
The Welsh Government has announced the creation of a £100m investment fund to support the expansion of the life sciences sector. [14-Mar-2012]
Comma Oil & Chemicals, the Kent-based supplier of lubricants and additives with 215 staff, is to be acquired by Cosan Group of Brazil for £63m. [05-Mar-2012]
Hale Group, the Widnes-based chemicals supplier trading as Forward Chemicals and Rexodan International, has been acquired by Zep Inc of the US for undisclosed terms. [05-Mar-2012]
DSM Composite Resins is to close its resins plant in Ellesmere Port later this year, with the loss of 45 jobs. [01-Mar-2012]
Moray Council has approved plans to build a £6.5m life sciences centre on the Moray College UHI campus in Elgin over the next year. [01-Mar-2012]
Penn Pharma is to invest £14m in the expansion of its Gwent-based pharmaceuticals business, including a new 15,000 sq ft tablet manufacturing unit. [29-Feb-2012]
Simcyp, the Sheffield-based drug development firm, has been sold by Fusion IP to Certara of the US for about £20m. [27-Feb-2012]
Bayer CropScience is to invest £10m in improvements to its site in Norwich by early 2013, including waste water facilities and computer control equipment. [22-Feb-2012]
P&L Systems of Knaresborough has acquired SX Environmental, the Southend-based pest control supplies firm, for undisclosed terms. [22-Feb-2012]
Xceleron has been sold in a pre-pack administration to a management team, and most of the 20 jobs at its York-based pharmaceutical development business will be lost as operations are transferred to the US. [20-Feb-2012]
Nexus Oncology, the Edinburgh-based cancer research firm with more than 120 staff, has been acquired by Ockham of the US for undisclosed terms. [16-Feb-2012]
Vernalis is to raise £65m in a share placing, having agreed a deal with US-based Tris Pharma to develop six prescription drugs. [13-Feb-2012]
Liz Earle is planning to expand its cosmetics production facility at the Ryde Business Park on the Isle of Wight, with the creation of 500 jobs. [06-Feb-2012]
AstraZeneca is to shed a further 7,300 jobs from its 61,000-strong global workforce over the next two years, which is expected to affect some its 8,000 staff in the UK. [02-Feb-2012]
Chime Communications is to acquire Succinct Communications, the provider of medical communications for prescription medicines, for an initial £2m. [02-Feb-2012]
Biotec Services International is planning to expand the workforce at its Bridgend-based clinical trials service from 39 to 55 over the next few months, having acquired 15,000 sq ft of additional space. [31-Jan-2012]
Sirius Minerals is to raise £50m in a share placing to fund the drilling programme for the York Potash Project near Whitby. [30-Jan-2012]
Immunodiagnostic Systems is looking to shed an unspecified number of the 300 jobs at its South Tyneside-based life sciences business. [25-Jan-2012]
INX International of the US is to set up a 40,000 sq ft ink manufacturing unit at the Hareshill Distribution Park near Rochdale in 2013, with the relocation of 68 jobs from the Transpennine Trading Estate. [23-Jan-2012]
Eastman Kodak has filed for bankruptcy protection in the US, which could affect some of the 1,200 staff at UK sites in Hemel Hempstead, Harrow and Leeds. [23-Jan-2012]
Babraham Institute has won permission to expand its life sciences research centre in Cambridgeshire with four new research buildings, which could create up to 400 jobs. [16-Jan-2012]
University of Liverpool and a number of partners have submitted plans for the development of the 70,000 sq ft Liverpool BioInnovation Centre at the proposed 2m sq ft BioCampus life sciences park. [16-Jan-2012]
BioCity and the Roslin BioCentre are to set up a science hub at the 23-acre former Merck site in Airdrie, with the creation of up to 500 jobs. [12-Jan-2012]
Speciality European Pharma has raised £2.5m to fund the expansion of its London-based pharmaceutical marketing business. [11-Jan-2012]
Imperial College London is submitting plans for a new 1m sq ft campus at White City, including a biomedical research facility, offices and a hotel. [09-Jan-2012]
Norgine is to shed 36 of the 400 jobs at its Hengoed-based pharmaceuticals business. [09-Jan-2012]
Chemoxy International, the speciality chemicals manufacturer with 80 staff in Middlesbrough and Billingham, has undergone a management buy-out from Dow Chemical. [05-Jan-2012]
PZ Cussons is to acquire the Fudge hair care brand from Sabre Group of Australia for £25m. [05-Jan-2012]